Moxonidine hydrochloride (Synonyms:盐酸莫索尼定)
目录号 : KM27804 CAS No. : 75536-04-8 纯度 : 98%
Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent.Target: I1-RMoxonidine Hydrochloride is a centrally acting antihypertensive agent. Mixed Nischarin (I1 imidazoline receptor) and α2-AR (adrenergic) agonist; displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors. Moxonidine reduced stimulated NE overflow (log EC50: -6.15 +/- 0.14). AGN192403, a selective ligand at I1-R, had no influence on the dose-response curve of moxonidine (log EC50: -6.01 +/- 0.25) . The hypotensive and bradycardic actions of moxonidine but not clonidine are mediated through imidazoline receptors and are dependent on intact noradrenergic pathways within the RVLM. Furthermore, the noradrenergic innervation may be associated with a 42 kDa imidazoline receptor protein .
规格 价格 是否有货 数量
50mg 询价 In-stock
100mg 询价 In-stock
250mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent.Target: I1-RMoxonidine Hydrochloride is a centrally acting antihypertensive agent. Mixed Nischarin (I1 imidazoline receptor) and α2-AR (adrenergic) agonist; displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors. Moxonidine reduced stimulated NE overflow (log EC50: -6.15 +/- 0.14). AGN192403, a selective ligand at I1-R, had no influence on the dose-response curve of moxonidine (log EC50: -6.01 +/- 0.25) . The hypotensive and bradycardic actions of moxonidine but not clonidine are mediated through imidazoline receptors and are dependent on intact noradrenergic pathways within the RVLM. Furthermore, the noradrenergic innervation may be associated with a 42 kDa imidazoline receptor protein .
体外研究

Moxonidine (10 μM; 48 h) hydrochloride can prevent mild decrease in myocardial cell viability/mitochondrial activity induced by IL-1 β and TNF - α.
Moxonidine (10 μM; 2 h) hydrochloride increases the uptake of oxidized low-density lipoprotein by vascular smooth muscle cells through α 2-adrenergic receptors.
Moxonidine (30 μM) hydrochloride inhibits voltage dependent N-type Ca2+currents by activating the imidazoline I1 receptor in rat cervical ganglion neurons.

体内研究

Moxonidine (18 mg/kg/day; Oral administration; Through drinking water) hydrochloride can reduce the formation of atherosclerosis in the aortic arch and left common carotid artery of ApoE -/- mice infused with Angiotensin II, and is accompanied by an increase in plasma lipid hydroperoxide level .
Moxinidine (100-1000 μg/kg; intravenous injection) and hydrochloride caused dose-dependent hypotension and bradycardia in awake wild-type mice.
Moxonidine (3-6 mg/kg/day; Implanting permeable micro pumps subcutaneously; 21 days) Hydrochloride inhibits sympathetic nervous activation caused by myocardial infarction in a dose-dependent manner, and high doses can restore normal ventricular weight to body weight ratio and interstitial collagen in myocardial infarction rats.
Moxinidine (20-80 nmol; intraventricular injection into the fourth ventricle) hydrochloride dose dependently reduces mean arterial pressure, heart rate, and sympathetic nerve output in conscious spontaneously hypertensive rats, with a stronger effect than injection into the lateral ventricle.

分子式
C9H13Cl2N5O
分子量
278.14
CAS号
75536-04-8
中文名称
盐酸莫索尼定
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式

2-8°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据
In Vitro:

DMSO : 100 mg/mL (359.53 mM; Need ultrasonic)

H2O : ≥ 100 mg/mL (359.53 mM)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.5953 mL 17.9766 mL 35.9531 mL
5 mM 0.7191 mL 3.5953 mL 7.1906 mL
10 mM 0.3595 mL 1.7977 mL 3.5953 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO→40% PEG300 → 5% Tween-80 → 45% saline

    Solubility: ≥ 2.5 mg/mL (8.99 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (8.99 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

  • 2.

    请依序添加每种溶剂: 10% DMSO → 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (8.99 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (8.99 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

  • 3.

    请依序添加每种溶剂: 10% DMSO → 90% corn oil

    Solubility: ≥ 2.5 mg/mL (8.99 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (8.99 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积:

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。